Ishii Masaki, Yamada Tsuyoshi, Ohata Shinya
Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, 202-8585, Japan.
Teikyo University Institute of Medical Mycology, Teikyo University, Hachioji, Tokyo, 192-0395, Japan.
AMB Express. 2024 Aug 31;14(1):96. doi: 10.1186/s13568-024-01755-8.
Trichophyton rubrum is one of the most frequently isolated fungi in patients with dermatophytosis. Despite its clinical significance, the molecular mechanisms of drug resistance and pathogenicity of T. rubrum remain to be elucidated because of the lack of genetic tools, such as efficient gene targeting systems. In this study, we generated a T. rubrum strain that lacks the nonhomologous end-joining-related gene ku80 (Δku80) and then developed a highly efficient genetic recombination system with gene targeting efficiency that was 46 times higher than that using the wild-type strain. Cyp51A and Cyp51B are 14-α-lanosterol demethylase isozymes in T. rubrum that promote ergosterol biosynthesis and are the targets of azole antifungal drugs. The expression of cyp51A mRNA was induced by the addition of the azole antifungal drug efinaconazole, whereas no such induction was detected for cyp51B, suggesting that Cyp51A functions as an azole-responsive Cyp51 isozyme. To explore the contribution of Cyp51A to susceptibility to azole drugs, the neomycin phosphotransferase (nptII) gene cassette was inserted into the cyp51A 3'-untranslated region of Δku80 to destabilize the mRNA of cyp51A. In this mutant, the induction of cyp51A mRNA expression by efinaconazole was diminished. The minimum inhibitory concentration for several azole drugs of this strain was reduced, suggesting that dermatophyte Cyp51A contributes to the tolerance for azole drugs. These findings suggest that an efficient gene targeting system using Δku80 in T. rubrum is applicable for analyzing genes encoding drug targets.
红色毛癣菌是皮肤癣菌病患者中最常分离出的真菌之一。尽管其具有临床意义,但由于缺乏有效的基因靶向系统等遗传工具,红色毛癣菌耐药性和致病性的分子机制仍有待阐明。在本研究中,我们构建了一个缺失非同源末端连接相关基因ku80(Δku80)的红色毛癣菌菌株,然后开发了一种高效的基因重组系统,其基因靶向效率比使用野生型菌株高46倍。Cyp51A和Cyp51B是红色毛癣菌中的14-α-羊毛甾醇脱甲基酶同工酶,可促进麦角甾醇生物合成,是唑类抗真菌药物的作用靶点。添加唑类抗真菌药物艾氟康唑可诱导cyp51A mRNA表达,而未检测到cyp51B有此类诱导现象,这表明Cyp51A作为一种对唑敏感的Cyp51同工酶发挥作用。为了探究Cyp51A对唑类药物敏感性的影响,将新霉素磷酸转移酶(nptII)基因盒插入Δku80的cyp51A 3'-非翻译区,以破坏cyp51A的mRNA稳定性。在该突变体中,艾氟康唑对cyp51A mRNA表达的诱导作用减弱。该菌株对几种唑类药物的最低抑菌浓度降低,这表明皮肤癣菌Cyp51A有助于对唑类药物产生耐受性。这些发现表明,利用红色毛癣菌中的Δku80构建的高效基因靶向系统可用于分析编码药物靶点的基因。